| HGNC Family | Forkhead boxes (FOX) |
| Name | forkhead box C2 |
| Description | This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nFOXC2 is emerging as a central effector in tumor progression, largely through its ability to govern epithelial‐to‐mesenchymal transition (EMT) and to impart stem‐like and invasive properties on cancer cells. Studies have shown that FOXC2 is up‐regulated during EMT induced by multiple stimuli (e.g., TGF‐β, Snail, Twist) and is required for metastasis in a variety of epithelial cancers, including breast, lung, colorectal, prostate, nasopharyngeal, and osteosarcoma. FOXC2 can promote mesenchymal differentiation by transcriptionally regulating key downstream effectors – such as MET, PDGFR‐β, and GD3 synthase – and its expression correlates with aggressive, basal‐like tumor phenotypes and chemoresistance. Its functional relevance is further highlighted by findings that inhibition of FOXC2 (or its upstream regulators such as p38 MAPK) restores epithelial characteristics, reduces circulating tumor cell numbers, and sensitizes resistant tumors to therapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in cancer, FOXC2 is critical for vascular and lymphatic development. Mutations in FOXC2 cause lymphedema–distichiasis syndrome, a dominantly inherited disorder characterized by lymphatic valve dysfunction, venous insufficiency, and aberrant eyelash growth. FOXC2 is indispensable for the proper formation and maintenance of lymphatic vessels and valves, and its loss or mutation leads to vascular instability and impaired mechanotransduction in endothelial cells. Moreover, its regulation of angiogenic genes—including those coding for integrins, CXCR4, and Dll4—underscores an important function in neovascularization. These roles are supported by investigations of both loss‐of‐function and, intriguingly, gain‐of‐function mutations in FOXC2, which together reveal the breadth of its impact on vascular homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition, FOXC2 participates in the regulation of metabolic processes and developmental programs. Investigations in both human subjects and animal models have linked FOXC2 expression in adipose tissue and muscle to improved insulin sensitivity and protection against diet‐induced obesity, implicating it in the pathogenesis of type 2 diabetes and gestational diabetes. Moreover, studies addressing cardiac morphogenesis and osteoblastogenesis have revealed that FOXC2 is responsive to bone anabolic agents and plays a part in skeletal development as well as potentially influencing congenital heart phenotypes. These observations suggest that, in addition to its oncogenic and vascular roles, FOXC2 is a versatile regulator in metabolic and developmental contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFOXC2 action is further modulated by intricate regulatory mechanisms that include post‐transcriptional control by noncoding RNAs and post‐translational modifications. Long noncoding RNAs – such as FOXC2‐AS1 and circPVT1 – have been shown to stabilize FOXC2 mRNA, thereby enhancing its oncogenic potential. Moreover, the subcellular localization and phosphorylation status of FOXC2 significantly influence its transcriptional activity, as underscored by structural studies that have refined our understanding of its DNA‐binding domain and of how specific mutations (or loss thereof) affect its function. These findings collectively point to a sophisticated network of regulatory inputs that fine‐tune FOXC2 function in both normal physiology and disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sendurai A Mani, Jing Yang, Mary Brooks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0703900104"}], "href": "https://doi.org/10.1073/pnas.0703900104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17537911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17537911"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Brett G Hollier, Agata A Tinnirello, Steven J Werden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-2962"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-2962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23378344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23378344"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Y-H Yu, H-A Chen, P-S Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.74"}], "href": "https://doi.org/10.1038/onc.2012.74"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22410781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22410781"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "T R Sarkar, V L Battula, S J Werden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.245"}], "href": "https://doi.org/10.1038/onc.2014.245"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25109336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25109336"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Y-M Cui, H-L Jiao, Y-P Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 promotes colorectal cancer metastasis by directly targeting MET."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.368"}], "href": "https://doi.org/10.1038/onc.2014.368"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25381815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25381815"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhijiao Zhou, Lu Zhang, Bowen Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2015.04.008"}], "href": "https://doi.org/10.1016/j.canlet.2015.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25896630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25896630"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "A N Paranjape, R Soundararajan, S J Werden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.498"}], "href": "https://doi.org/10.1038/onc.2015.498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26804168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26804168"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Thao N D Pham, Bethany E Perez White, Huiping Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3827-y"}], "href": "https://doi.org/10.1186/s12885-017-3827-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29216867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29216867"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ming Yan, Hang Gao, Zhenshan Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15215"}], "href": "https://doi.org/10.1111/jcmm.15215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32249539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32249539"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Lijuan Song, Hongbo Tang, Wenjing Liao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2017.04.019"}], "href": "https://doi.org/10.1016/j.yexcr.2017.04.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28433696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28433696"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "G Brice, S Mansour, R Bell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.39.7.478"}], "href": "https://doi.org/10.1136/jmg.39.7.478"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12114478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12114478"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Amélie Sabine, Esther Bovay, Cansaran Saygili Demir, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI80454"}], "href": "https://doi.org/10.1172/JCI80454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26389677"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26389677"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Russell H Mellor, Glen Brice, Anthony W B Stanton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.106.675348"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.106.675348"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17372167"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17372167"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "R P Erickson, S L Dagenais, M S Caulder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.38.11.761"}], "href": "https://doi.org/10.1136/jmg.38.11.761"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11694548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11694548"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "David N Finegold, Vivien Schacht, Mark A Kimak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HGF and MET mutations in primary and secondary lymphedema."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lymphat Res Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/lrb.2008.1524"}], "href": "https://doi.org/10.1089/lrb.2008.1524"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18564920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18564920"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Anees Fatima, Ying Wang, Yutaka Uchida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI80465"}], "href": "https://doi.org/10.1172/JCI80465"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27214551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27214551"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Tsutomu Kume "}, {"type": "b", "children": [{"type": "t", "text": "Foxc2 transcription factor: a newly described regulator of angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Trends Cardiovasc Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.tcm.2008.11.003"}], "href": "https://doi.org/10.1016/j.tcm.2008.11.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19185813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19185813"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Teng Wang, Lei Zheng, Qian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Emerging roles and mechanisms of FOXC2 in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2018.01.019"}], "href": "https://doi.org/10.1016/j.cca.2018.01.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29341903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29341903"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Elias I Traboulsi, Khouloud Al-Khayer, Masayuki Matsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lymphedema-distichiasis syndrome and FOXC2 gene mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Ophthalmol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0002-9394(02)01642-2"}], "href": "https://doi.org/10.1016/s0002-9394(02"}, {"type": "t", "text": "01642-2) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12383817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12383817"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Y Li, W Yang, Q Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-27.475"}], "href": "https://doi.org/10.14670/HH-27.475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22374725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22374725"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Russell H Mellor, Naomi Tate, Anthony W B Stanton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in FOXC2 in humans (lymphoedema distichiasis syndrome) cause lymphatic dysfunction on dependency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Vasc Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000323484"}], "href": "https://doi.org/10.1159/000323484"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21464574"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21464574"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Konstantin I Ivanov, Yan Agalarov, Leena Valmu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01387-12"}], "href": "https://doi.org/10.1128/MCB.01387-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23878394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23878394"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "M Bahuau, C Houdayer, M Tredano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1034/j.1399-0004.2002.620608.x"}], "href": "https://doi.org/10.1034/j.1399-0004.2002.620608.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12485195"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12485195"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Sridhar Hannenhalli, Mary E Putt, Joan M Gilmore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional genomics associates FOX transcription factors with human heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.106.632430"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.106.632430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16952980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16952980"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "M Iascone, R Ciccone, L Galletti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of de novo mutations and rare variants in hypoplastic left heart syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2011.01674.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2011.01674.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21457232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21457232"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "N Shaat, A Lernmark, E Karlsson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-007-0623-2"}], "href": "https://doi.org/10.1007/s00125-007-0623-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17342473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17342473"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Kalliopi I Pappa, Maria Gazouli, Konstantinos Economou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gynecol Endocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/09513590.2010.490609"}], "href": "https://doi.org/10.3109/09513590.2010.490609"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20540670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20540670"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Martin E Lidell, Erin L Seifert, Rickard Westergren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The adipocyte-expressed forkhead transcription factor Foxc2 regulates metabolism through altered mitochondrial function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db10-0409"}], "href": "https://doi.org/10.2337/db10-0409"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21270254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21270254"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Gwo-Chin Ma, Chin-San Liu, Shun-Ping Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prenat Diagn (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pd.2130"}], "href": "https://doi.org/10.1002/pd.2130"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18973153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18973153"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Su Jin Park, Jogeswar Gadi, Kyoung-Won Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The forkhead transcription factor Foxc2 promotes osteoblastogenesis via up-regulation of integrin β1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bone (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bone.2011.05.012"}], "href": "https://doi.org/10.1016/j.bone.2011.05.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21640215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21640215"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Chun-Lin Zhang, Kun-Peng Zhu, Xiao-Long Ma "}, {"type": "b", "children": [{"type": "t", "text": "Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.03.018"}], "href": "https://doi.org/10.1016/j.canlet.2017.03.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28323030"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28323030"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "C Hader, A Marlier, L Cantley "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.397"}], "href": "https://doi.org/10.1038/onc.2009.397"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19935708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19935708"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Fred B Berry, Yahya Tamimi, Michelle V Carle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddi295"}], "href": "https://doi.org/10.1093/hmg/ddi295"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16081467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16081467"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Xiaojuan Chen, Hudie Wei, Jun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for DNA recognition by FOXC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkz077"}], "href": "https://doi.org/10.1093/nar/gkz077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30722065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30722065"}]}]}]}
|
| Synonyms | LD, FKHL14, MFH1, MFH-1 |
| Proteins | FOXC2_HUMAN |
| NCBI Gene ID | 2303 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
FOXC2 has 7,162 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 111 datasets.
Click the + buttons to view associations for FOXC2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of FOXC2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of FOXC2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of FOXC2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of FOXC2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of FOXC2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of FOXC2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of FOXC2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of FOXC2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with FOXC2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of FOXC2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of FOXC2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of FOXC2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with FOXC2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with FOXC2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of FOXC2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of FOXC2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing FOXC2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing FOXC2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with FOXC2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with FOXC2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of FOXC2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with FOXC2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with FOXC2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with FOXC2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by FOXC2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for FOXC2 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving FOXC2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with FOXC2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with FOXC2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with FOXC2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with FOXC2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with FOXC2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at FOXC2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of FOXC2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of FOXC2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing FOXC2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with FOXC2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with FOXC2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of FOXC2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with FOXC2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing FOXC2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of FOXC2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving FOXC2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving FOXC2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving FOXC2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing FOXC2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing FOXC2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing FOXC2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by FOXC2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by FOXC2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by FOXC2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of FOXC2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of FOXC2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with FOXC2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with FOXC2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with FOXC2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of FOXC2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of FOXC2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with FOXC2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with FOXC2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with FOXC2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for FOXC2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of FOXC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of FOXC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of FOXC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of FOXC2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with FOXC2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of FOXC2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of FOXC2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing FOXC2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain FOXC2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by FOXC2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of FOXC2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by FOXC2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with FOXC2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for FOXC2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of FOXC2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of FOXC2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving FOXC2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving FOXC2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with FOXC2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| Reactome Pathways 2024 | pathways involving FOXC2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of FOXC2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at FOXC2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of FOXC2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of FOXC2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of FOXC2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with FOXC2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of FOXC2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of FOXC2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of FOXC2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of FOXC2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of FOXC2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of FOXC2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of FOXC2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of FOXC2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of FOXC2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with FOXC2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with FOXC2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving FOXC2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving FOXC2 protein from the WikiPathways Pathways 2024 dataset. | |